Cure8 research brief
Capsaicin is commonly consumed and acts on TRPV1, which is increased in inflamed IBD tissue; depending on dose and disease activity it may help or worsen inflammation and symptom-related pain.
Adults with IBD, clinicians advising patients on diet or symptom triggers, and researchers studying TRPV1, diet–microbiome interactions, or novel therapeutic targets.
This is a review article summarizing preclinical and mechanistic research about capsaicin and TRPV1 in inflammatory bowel disease.
The authors report that capsaicin has multiple potential protective actions in animal models (anti-inflammatory effects, mucosal protection, effects on the microbiota and microcirculation) but that higher doses, certain administration routes, and presence of active inflammation are linked to adverse, TRPV1-mediated effects such as burning pain and neurogenic inflammation.
The review emphasizes a bell-shaped dose–response: low-to-moderate exposure may be beneficial in some experimental settings while higher exposure can be harmful.
The paper discusses how dose, route, duration, and disease stage influence whether capsaicin acts as “friend or foe.” This summary is based on the article abstract provided by the journal; Cure8 did not review the full paper beyond the supplied abstract and metadata.
This article is a mechanistic review largely of preclinical evidence. Findings from animal and lab studies do not directly translate into clinical recommendations. The abstract was the source for this brief; the full article may contain additional details.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declarations. Conflict of interest: The authors declare that they have no conflict of interest.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Vitamin D appears linked to immune regulation, gut barrier health, and the microbiome—processes relevant to IBD and other intestinal disorders. Understanding this could affect how clinicians monitor and study vitamin D...
A potential link between ultra-processed food intake and Crohn’s relapse could influence dietary conversations for people in remission, but the current evidence is weak and not definitive.
Diet is a modifiable factor that appears to change the gut microbiome and may affect symptoms and inflammation in both IBS and IBD; understanding which patterns help could guide practical dietary advice.
